CINECA IRIS Institutional Research Information System

ROSSI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.245
SA - Sud America 562
NA - Nord America 465
EU - Europa 374
AF - Africa 37
OC - Oceania 2
Totale 2.685
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 435
US - Stati Uniti d'America 411
SG - Singapore 307
VN - Vietnam 301
CN - Cina 205
HK - Hong Kong 202
DE - Germania 127
KR - Corea 112
IT - Italia 70
FR - Francia 66
AR - Argentina 60
EC - Ecuador 26
ID - Indonesia 23
MX - Messico 22
BD - Bangladesh 21
GB - Regno Unito 21
PL - Polonia 17
IN - India 15
CA - Canada 14
UA - Ucraina 13
CO - Colombia 12
RU - Federazione Russa 12
IQ - Iraq 11
ZA - Sudafrica 11
EG - Egitto 8
PY - Paraguay 7
CL - Cile 6
FI - Finlandia 6
NL - Olanda 6
VE - Venezuela 6
BG - Bulgaria 5
ES - Italia 5
MA - Marocco 5
PE - Perù 5
PK - Pakistan 5
SE - Svezia 5
TN - Tunisia 5
UY - Uruguay 5
CR - Costa Rica 4
HU - Ungheria 4
JM - Giamaica 4
KZ - Kazakistan 4
SA - Arabia Saudita 4
TR - Turchia 4
JO - Giordania 3
PH - Filippine 3
PR - Porto Rico 3
PS - Palestinian Territory 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
KE - Kenya 2
KW - Kuwait 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
TH - Thailandia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
KG - Kirghizistan 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MR - Mauritania 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 2.685
Salva come PNG Salva come JPEG
Città #
Hong Kong 202
Seoul 112
Ho Chi Minh City 104
Frankfurt am Main 90
Singapore 86
Ashburn 69
Hanoi 60
Chicago 55
Beijing 52
São Paulo 36
New York 32
San Jose 32
Munich 28
Hillsboro 20
Rio de Janeiro 18
Haiphong 16
Da Nang 15
Curitiba 11
Naples 11
Warsaw 11
Los Angeles 10
Mexico City 10
Dallas 9
Guayaquil 9
Porto Alegre 9
Seattle 9
Bexley 8
Can Tho 8
Santa Clara 8
Biên Hòa 7
Salvador 7
Belo Horizonte 6
Brasília 6
Florence 6
Ha Long 6
Hải Dương 6
Newark 6
Quito 6
Santo André 6
Aversa 5
Bauru 5
Cairo 5
Fortaleza 5
Jakarta 5
Kyiv 5
London 5
Ninh Bình 5
Resistencia 5
Sorocaba 5
Stockholm 5
Thái Bình 5
Turku 5
Wroclaw 5
Asunción 4
Baghdad 4
Barbacena 4
Buenos Aires 4
Buffalo 4
Bắc Ninh 4
Campinas 4
Campo Grande 4
Council Bluffs 4
Formosa 4
Juiz de Fora 4
Lima 4
Montreal 4
Recife 4
Roubaix 4
Sofia 4
Toronto 4
Amman 3
Brooklyn 3
Cape Town 3
Contagem 3
Guarujá 3
Guarulhos 3
Jacareí 3
Johannesburg 3
Kingston 3
Limeira 3
Madrid 3
Milan 3
Montevideo 3
Mumbai 3
Natal 3
Nha Trang 3
Petrópolis 3
Phủ Lý 3
Praia Grande 3
Reston 3
Serra 3
Sumaré 3
São Gonçalo 3
Taubaté 3
Thái Nguyên 3
Uberaba 3
Villa Ballester 3
Almaty 2
Amsterdam 2
Araraquara 2
Totale 1.427
Salva come PNG Salva come JPEG
Nome #
Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study 61
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 57
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System 57
Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database - A Case Study 56
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 55
Current and future therapeutic perspective in chronic heart failure 54
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 52
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 49
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 48
Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomerase 47
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System 46
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 46
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 46
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 45
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 44
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 43
Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age 43
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 43
Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? 43
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 42
Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study 42
Glucocorticoid-induced leucine zipper (Gilz) in cardiovascular health and disease 41
Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury 41
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome 41
Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity 40
COVID-19 and atrial fibrillation: Intercepting lines 40
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? 39
Current pharmacological treatments for COVID-19: What's next? 39
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 39
Tisagenlecleucel in children and young adults: Reverse translational research by using real‐world safety data 38
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects 38
Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction 38
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 38
Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data 37
Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management 37
Pharmacological, Technological, and Digital Innovative Aspects in Rhinology 37
Statins stimulate new myocyte formation after myocardial infarction by activating growth and differentiation of the endogenous cardiac stem cells 36
Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines 36
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting 36
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years 36
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 35
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 35
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 35
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment 34
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 34
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database 34
Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch 34
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines 33
The safety profile of general and local anaesthetic agents: Data collected during 20 years of spontaneous reporting activities in the campania region (southern italy) 33
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 33
The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review 32
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System 32
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase® 32
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review 32
Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study 32
Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey 31
A case of figurate urticaria by etanercept 30
Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System 30
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 30
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta‐blocker use: a Danish nationwide cohort study 29
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 29
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 29
Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis 28
Therapeutic strategies to fight COVID‐19: Which is the status artis? 27
Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study 27
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 27
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting syste 26
The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure 26
Relationship Between Gender and the Effectiveness of Montelukast: An Italian/Danish Register-Based Retrospective Cohort Study 26
Effects of sacubitril-valsartan on aging-related cardiac dysfunction 26
Utilizing clinical pharmacology in the drug repurposing arena: a look into COVID-19 25
Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study 25
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 22
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 22
Italian immunization goals: A political or scientific heated debate? 11
Intervention studies and antimicrobial resistance in Italy: An overview of the latest evidence 9
Unmasking counterfeit semaglutide: analysis of real-world safety data from EudraVigilance 5
Safety profile of FLT3 inhibitors in acute myeloid leukemia: a systematic review and meta-analysis of adverse events 1
Totale 2.787
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.730
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025584 0 0 0 3 39 173 70 50 45 46 117 41
2025/20262.203 147 133 408 525 207 66 43 170 181 249 74 0
Totale 2.787